Health Resilience & Medical Dual‑Use

Aerois Capital - Sectors

Seed & Early Stage Criteria

The same bar we apply across every sector we back — adapted here to defense procurement realities.

Single & Dual‑Use

Technologies with defence and commercial applications, not defence‑only dead ends.

Strong Teams

Founders with relevant technical or industry expertise and credibility with buyers.

Path to Market

A clear, defensible route to market share — not just a compelling demo.

Emerging Threats

Technologies addressing capabilities and threats that are only now becoming real.

Where We'd Look

Fully drafted — no source copy supplied, confirm before publishing.

Military Medicine

Battlefield care, trauma response, and casualty evacuation technology.

Biosecurity & CBRN

Detection and defence against biological, chemical, and radiological threats.

Health Data Security

Protecting clinical and biometric data as sensitive national infrastructure.

Dual‑Use Med‑Tech

Devices and diagnostics built for the field that also serve civilian care.

More Than Capital

Industry Expertise

Deep understanding of both the complex defence industry and the venture landscape — including partners who are former senior US and Israeli officers with first‑hand procurement experience.

Hands‑On Support

Active involvement in portfolio companies, helping navigate regulatory requirements and government relations.

Strategic Capital

More than funding — capital paired with the relationships that help defence tech companies scale into worldwide markets.

Network

Access to our network of partners, advisors, and decision‑makers across the defence and security sectors.

We're open‑minded — if you're building something real, we want to hear it.

Our stated sectors describe where we spend most of our time, not the edge of what we'll consider. If your technology defends critical infrastructure or strengthens national resilience, talk to us even if it doesn't fit neatly into a category above. Contact Aerois Capital